← Back to Search

Aspirin for Breast cancer

Phase 3
Waitlist Available
Research Sponsored by Alliance for Clinical Trials in Oncology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
Pivotal Trial

Summary

This trial is testing if taking aspirin regularly can help prevent breast cancer from returning in patients who have already had other treatments. Aspirin works by reducing inflammation and blood clotting, which may make it harder for cancer to come back. Aspirin has been studied extensively for its potential to prevent cancer recurrence, with evidence suggesting it may improve survival rates in cancer patients.

Eligible Conditions
  • Breast cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Median Invasive Disease-free Survival (iDFS)
Secondary study objectives
Median Distant Disease Free Survival (DDFS)
Median Overall Survival (OS)

Awards & Highlights

Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Arm I (aspirin)Experimental Treatment1 Intervention
Patients receive aspirin PO QD for five years in the absence of disease progression or unacceptable toxicity.
Group II: Arm II (Placebo)Placebo Group1 Intervention
Patients receive placebo PO QD for five years in the absence of disease progression or unacceptable toxicity.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Aspirin
2014
Completed Phase 4
~55580

Find a Location

Who is running the clinical trial?

Alliance for Clinical Trials in OncologyLead Sponsor
516 Previous Clinical Trials
217,900 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,906 Previous Clinical Trials
41,009,011 Total Patients Enrolled
United States Department of DefenseFED
906 Previous Clinical Trials
330,349 Total Patients Enrolled
~339 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top